Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

New dosing regimen of Avax melanoma vaccine results in improved outcome

June 17, 1998

Biomira and Chiron expand Theratope cancer vaccine agreement

June 17, 1998

Combination immunotherapy of renal cell carcinoma: efficacy established in phase II trial

June 11, 1998

Excellent phase III results reported for bropirimine in CIS

June 11, 1998

Encouraging results reported for Cel-Sci's Multikine

June 11, 1998

Immunex's CD40 Ligand enters phase I

June 10, 1998

Initiation of late-stage Avicine clinical trial

June 9, 1998

Genzyme Molecular Oncology and Dana-Farber agreement for fusion cell technology

June 5, 1998

Vical reports initial results from gene-based immunotherapy for prostate cancer

June 4, 1998

FDA advisory committee recommends approval of Ontak for CTCL

June 3, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
GLP-1s need technologies for long-term use
BioWorld
For the long-term impact of GLP-1 therapies in obesity to be realized, they must be paired with data and digital tools. While the drugs are effective, challenges...
UTRN gene involved in arthrogryposis, study finds
BioWorld Science
Arthrogryposis multiplex congenita (AMC) is a group of disorders defined by two or more contractures in different body areas; while genes encoding sarcomeric...
HMNC raises $50M series B to prep depression drugs for phase III
BioWorld
HMNC Brain Health GmbH has raised $50 million in the first close of a series B, enabling the company to prepare the way for phase III trials of its two lead...
CFTX-2034 successfully shows promise for post-bariatric hypoglycemia in preclinical research
BioWorld Science
Researchers from Confo Therapeutics NV presented the preclinical characterization of CFTX-2034, a selective somatostatin receptor subtype 5 (SSTR5) agonist...